Treatment with rituximab was scheduled but repeat viral screening revealed newly diagnosed HIV infection with advanced immunodeficiency (HIV-RNA 1500000 copies/mL, CD4 + lymphocyte count 135/uL (12%) and CD4/CD8 ratio 0.19 at baseline). This evidence concerns the gene CD8A and HIV infectious disease.